HeartBeam Inc. (BEAT)
NASDAQ: BEAT
· Real-Time Price · USD
1.64
0.01 (0.61%)
At close: Sep 25, 2025, 10:09 AM
HeartBeam Revenue Breakdown
| Period Ending | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| TechnologyDevicesConsumablesandRelatedServices Revenue | 4.07M | 3.27M | 3.5M | 3.54M | 3.18M | 2.92M | 3.01M | 13.31M | 2.35M | 2.09M |
| TechnologyDevicesConsumablesandRelatedServices Revenue Growth | +24.54% | -6.74% | -0.88% | +11.09% | +8.97% | -2.86% | -77.41% | +465.53% | +12.53% | n/a |
| ClinicalTrialSupportandRelatedServices Revenue | 12.12M | 11.46M | 13.82M | 13.37M | 14.24M | 13.88M | 12.96M | 51.19M | 13.46M | 12.55M |
| ClinicalTrialSupportandRelatedServices Revenue Growth | +5.74% | -17.08% | +3.36% | -6.08% | +2.57% | +7.06% | -74.68% | +280.23% | +7.32% | n/a |
| MonitoringCommercial Revenue | 57.05M | 41.4M | 55.58M | 55.96M | 54.34M | 58.91M | 54.07M | 36.15M | 49.56M | 50.12M |
| MonitoringCommercial Revenue Growth | +37.81% | -25.51% | -0.68% | +2.99% | -7.76% | +8.94% | +49.59% | -27.06% | -1.13% | n/a |
| MonitoringMedicare Revenue | 41.42M | 33.28M | 40.13M | 39.17M | 39.54M | 36.1M | 33.94M | 2.95M | 34.64M | 36.6M |
| MonitoringMedicare Revenue Growth | +24.45% | -17.06% | +2.45% | -0.93% | +9.53% | +6.37% | +1048.78% | -91.47% | -5.36% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 1.71M | 2.01M | 2.06M | 2.18M | 2.25M | 2.36M | 2.1M | 2.11M | 1.83M | 2.48M | 2.1M | 2.05M | 1.79M | 1.41M | 1.25M | 341K | 312K | 134K | 214K | 215K | 133K | 93K | 45.1M | 42.22M | 43.38M | 41.02M | 38.79M | 36.86M | 40.34M | 39.29M | 35.47M | 39.5M | 24.17M | 24.78M | 22.38M | 21.02M | 21.79M | 20.05M | 19.99M | 18.14M | 19.14M | 18.59M |
| Selling, General, and Administrative Revenue Growth | -14.96% | -2.24% | -5.42% | -3.12% | -4.67% | +12.24% | -0.71% | +15.65% | -26.14% | +17.97% | +2.44% | +14.22% | +26.80% | +13.57% | +265.10% | +9.29% | +132.84% | -37.38% | -0.47% | +61.65% | +43.01% | -99.79% | +6.83% | -2.67% | +5.76% | +5.75% | +5.23% | -8.63% | +2.69% | +10.76% | -10.20% | +63.44% | -2.46% | +10.72% | +6.49% | -3.56% | +8.68% | +0.30% | +10.19% | -5.23% | +2.97% | n/a |
| Research and Development Revenue | 3.33M | 3.49M | 2.89M | 2.89M | 2.84M | 2.43M | 2.01M | 1.62M | 1.48M | 1.68M | 1.64M | 1.56M | 1.74M | 734K | 96K | 105K | 25K | 29K | 47K | 57K | 21K | 7K | 3.47M | 3.66M | 3.53M | 3.33M | 2.75M | 2.43M | 2.73M | 3.29M | 2.88M | 3.28M | 2.52M | 2.43M | 2.47M | 2.14M | 1.97M | 1.79M | 1.95M | 1.56M | 1.63M | 1.97M |
| Research and Development Revenue Growth | -4.75% | +21.00% | -0.24% | +1.72% | +17.13% | +20.80% | +23.84% | +9.37% | -11.72% | +2.44% | +5.06% | -10.33% | +137.33% | +664.58% | -8.57% | +320.00% | -13.79% | -38.30% | -17.54% | +171.43% | +200.00% | -99.80% | -5.27% | +3.65% | +5.97% | +20.98% | +13.42% | -11.12% | -16.90% | +14.36% | -12.24% | +30.30% | +3.37% | -1.38% | +15.44% | +8.75% | +10.02% | -8.41% | +24.60% | -4.05% | -17.00% | n/a |